Penzkofer, Tobias http://orcid.org/0000-0001-9591-8575
Article History
Received: 13 May 2024
Revised: 13 May 2024
Accepted: 28 May 2024
First Online: 20 June 2024
Compliance with ethical standards
:
: The scientific guarantor of this publication is T.P.
: The author of this manuscript declares relationships with the following companies: research agreements (no personal payments) with AGO, Aprea AB, ARCAGY-GINECO, Astellas Pharma Global Inc. (APGD), Astra Zeneca, Clovis Oncology, Inc., Holaira, Incyte Corporation, Karyopharm, Lion Biotechnologies, Inc., MedImmune, Merck Sharp & Dohme Corp, Millennium Pharmaceuticals, Inc., Morphotec Inc., NovoCure Ltd., PharmaMar S.A. and PharmaMar USA, Inc., Roche, Siemens Healthineers, and TESARO Inc., and fees for a book translation (Elsevier B.V.).
: No complex statistical methods were necessary for this paper.
: Written informed consent was not required.
: Institutional Review Board approval was not required.
: Not applicable.
: